tm logo
KOARMVI
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 04 Dec 2024

Last Applicant/ Owned by

66 Hudson Boulevard East

New York

NY

10001-2192

Serial Number

98704971 filed on 19th Aug 2024

Registration Number

N/A

Correspondent Address

Tiffany Trunko

Tiffany Trunko Pfizer Inc.

New York, NY 10001-2192

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KOARMVI

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disor Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98704971

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T 447028

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
30th Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
25th Nov 2024ASSIGNED TO EXAMINER
19th Aug 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19th Aug 2024NEW APPLICATION ENTERED